A detailed history of Hbc Financial Services, Pllc transactions in Moderna, Inc. stock. As of the latest transaction made, Hbc Financial Services, Pllc holds 5 shares of MRNA stock, worth $202. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5
Previous 15 66.67%
Holding current value
$202
Previous $1,000 100.0%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

SELL
$63.64 - $125.14 $636 - $1,251
-10 Reduced 66.67%
5 $0
Q3 2021

Nov 02, 2021

BUY
$221.9 - $484.47 $3,328 - $7,267
15 New
15 $4,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $15.8B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Hbc Financial Services, Pllc Portfolio

Follow Hbc Financial Services, Pllc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hbc Financial Services, Pllc, based on Form 13F filings with the SEC.

News

Stay updated on Hbc Financial Services, Pllc with notifications on news.